BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials

Documenti analoghi

• A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology
  di: Jun Zhang, et al.
  Pubblicazione: (2024)
• Evaluating Safety Rules in Ongoing Dose‐Escalation Trials Using BOIN : A Comparative Analysis of Criteria and Their Impact on Dose‐Level Safety Assessments
  di: Stefan Englert, et al.
  Pubblicazione: (2026)
• A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
  di: Yingjie Qiu, et al.
  Pubblicazione: (2024)
• Informing the Borrowing Process for Dose‐Finding Trials by Estimating the Similarity Between Population‐Specific Dose‐Toxicity Curves
  di: Dario Zocholl, et al.
  Pubblicazione: (2025)
• Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
  di: Ping Gao, et al.
  Pubblicazione: (2025)